Prospective study of abdominal adiposity and gallstone disease in US men

American Journal of Clinical Nutrition

Volumn 80, Issue 1, 2004, Pages 38-44

  Tsai, Chung Jyi ^a   Leitzmann, Michael F ^b   Willett, Walter C ^b   Giovannucci, Edward L ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b NONE

Author keywords

Abdominal adiposity; Epidemiology; Gallstones; Men

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLELITHIASIS; COHORT ANALYSIS; COMPARATIVE STUDY; FOLLOW UP; HEALTH PRACTITIONER; HUMAN; INCIDENCE; MALE; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; ABDOMEN; ADIPOSE TISSUE; ANTHROPOMETRY; BODY CONSTITUTION; GALLSTONE; HISTOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; UNITED STATES;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRY; BODY CONSTITUTION; BODY MASS INDEX; COHORT STUDIES; FOLLOW-UP STUDIES; GALLSTONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 3042737714     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.1.38     Document Type: Article

References (46)

1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999;117:632-9.
2. National Hospital Discharge Survey: 2000 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2003:153.
3. Cohen DE. Pathogenesis of gallstones. In: Zakim D, Boyer TD, eds. Hepatology: a textbook of liver disease. 4th ed. Philadelphia: WB Saunders, 2002:1713-43.
4. Diehl AK, Schwesinger WH, Holleman DR Jr, Chapman JB, Kurtin WE. Gallstone characteristics in Mexican Americans and non-Hispanic whites. Dig Dis Sci 1994;39:2223-8.
5. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993;119:1029-35.
6. Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 1992;55:652-8.
7. Maclure KM, Hayes KC, Colditz GA, Stampfer MJ, Speizer FE, Willett WC. Weight, diet, and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989;321:563-9.
8. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol 1990;131:836-44.
9. Attili AF, Capocaccia R, Carulli N, et al. Factors associated with gallstone disease in the MICOL experience. Hepatology 1997;26:809-18.
10. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987;7:913-7.
11. Kono S, Kochi S, Ohyama S, Wakisaka A. Gallstones, serum lipids, and glucose tolerance among male officials of self-defense forces in Japan. Dig Dis Sci 1988;33:839-44.
12. Scragg RKR, McMichael AJ, Baghurst PA. Diet, alcohol and relative weight in gallstone disease: a case-control study. Br Med J (Clin Res Ed) 1984;288:1113-9.
13. Michels KB, Greenland S, Rosner BA. Does body mass index adequately capture the relation of body composition and body size to health outcomes? Am J Epidemiol 1998;147:167-72.
14. Carey V, Walters E, Colditz G, et al. Body fat distribution and risk of non-insulin-dependent diabetes in women. Am J Epidemiol 1997;145:614-9.
15. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
16. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-60.
17. Dubrac S, Parquet M, Blouquit Y, et al. Insulin injections enhance cholesterol gallstone incidence by changing the biliary cholesterol saturation index and apo A-I concentration in hamsters fed a lithogenic diet. J Hepatol 2001;35:550-7.
18. Ruhl CE, Everhart JE. Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease. Hepatology 2001;34:877-83.
19. Haffner SM, Diehl AK, Stern MP, Hazuda HP. Central adiposity and gallbladder disease in Mexican Americans. Am J Epidemiol 1989;129:587-95.
20. Heaton KW, Braddon FEM, Emmett PM, et al. Why do men get gallstones? Roles of abdominal fat and hyperinsulinemia. Eur J Gastroenterol Hepatol 1991;3:745-51.
21. Everhart JE, Yeh F, Lee ET, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology 2002;35:1507-12.
22. Kodama H, Kono S, Todoroki I, et al. Gallstone disease risk in relation to body mass index and waist-to-hip ratio in Japanese men. Int J Obes Relat Metab Disord 1999;23:211-6.
23. Kono S, Shinchi K, Todoroki I, et al. Gallstone disease among Japanese men in relation to obesity, glucose intolerance, exercise, alcohol use, and smoking. Scand J Gastroenterol 1995;30:372-6.
24. Gonzalez Villalpando C, Rivera Martinez D, Arredondo Perez B, et al. High prevalence of cholelithiasis in a low income Mexican population: an ultrasonographic survey. Arch Med Res 1997;28:543-7.
25. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC. Effectiveness of various mailing strategies among non-respondents in a prospective cohort study. Am J Epidemiol 1990;131:1068-71.
26. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1990;1:466-73.
27. Willett WC. Nutritional epidemiology. 2nd ed. New York: Oxford University Press, 1998.
28. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
29. Rothman KJ, Greenland S. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins, 1998.
30. Cupples LA, D'Agostino RB, Anderson K, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1988;7:205-22.
31. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990;9:1501-15.
32. Rosner B, Hennekens CH, Kass EH, Miall WE. Age-specific correlations analysis of longitudinal blood pressure data. Am J Epidemiol 1977;106:306-13.
33. Fischer J, Johnson MA. Low body weight and weight loss in the aged. J Am Diet Assoc 1990;90:1697-706.
34. Forbes GB, Reina JC. Adult lean body mass declines with age: some longitudinal observations. Metabolism 1970;19:653-63.
35. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986;44:739-46.
36. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62.
37. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostate hyperplasia. Am J Epidemiol 1994;140:989-1002.
38. Despres JP. Health consequences of visceral obesity. Ann Med 2001;33:534-41.
39. Grundy SM. Metabolic complications of obesity. Endocrine 2000;13:155-65.
40. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993;14:72-93.
41. Hendel HW, Hojgaard L, Andersen T, et al. Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intraabdominal fat masses in obese non-diabetic subjects. Int J Obes Relat Metab Disord 1998;22:294-302.
42. Petroni ML. Gallbladder motor function in obesity. Aliment Pharmacol Ther 2000;14(suppl):48-50.
43. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974;160:387-96.
44. Chait A, Bierman EL, Albers JJ. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J Clin Invest 1979;64:1309-19.
45. Gielkens HAJ, Lam WF, Coenraad M, et al. Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol 1998;28:595-602.
46. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology 2000;31:299-303.